Antimicrobial stewardship program directed at broad-spectrum intravenous antibiotics prescription in a tertiary hospital

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 28, Issue 12, 2009, Pages 1447-1456

  Cheng, V C C ^a   To, K K W ^a   Li, I W S ^a   Tang, B S F ^a   Chan, J F W ^a   Kwan, S ^a   Mak, R ^a   Tai, J ^a   Ching, P ^a   Ho, P L ^a   Seto, W H ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHANE; ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; COMPLIANCE (PHYSICAL); COST EFFECTIVENESS ANALYSIS; FEEDBACK SYSTEM; HUMAN; INFECTION CONTROL; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; ATTITUDE OF HEALTH PERSONNEL; BACTERIAL INFECTIONS; DRUG UTILIZATION; GUIDELINE ADHERENCE; HEALTH SERVICES RESEARCH; HOSPITALS; HUMANS; ORGANIZATIONAL POLICY; PRESCRIPTIONS;

EID: 71349084037     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-009-0803-8     Document Type: Article

References (36)

1. RD Smith 1999 Antimicrobial resistance: the importance of developing long-term policy Bull World Health Organ 77 862 1:STN:280: DC%2BD3c%2FmtVKhsg%3D%3D 10593035
2. JM Bell JD Turnidge SENTRY APAC 2002 High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998-1999 Antimicrob Agents Chemother 46 879 881 10.1128/AAC.46.3.880- 882.2002 1:CAS:528:DC%2BD38XhsVKhu7o%3D 11850278 (Pubitemid 34157680)
3. PL Ho WS Tse KW Tsang TK Kwok TK Ng VC Cheng RM Chan 2001 Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study Clin Infect Dis 32 701 707 10.1086/319222 1:STN:280:DC%2BD3MvjsVGnsA%3D%3D 11229837 (Pubitemid 32221927)
4. PL Ho RW Yung DN Tsang TL Que M Ho WH Seto TK Ng WC Yam WW Ng 2001 Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000 J Antimicrob Chemother 48 659 665 10.1093/jac/48.5.659 1:CAS:528:DC%2BD3MXovVyku70%3D 11679555
5. PL Ho TL Que SS Chiu RW Yung TK Ng DN Tsang WH Seto YL Lau 2004 Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001 Emerg Infect Dis 10 1250 1257 1:CAS:528:DC%2BD2cXmt1yguro%3D 15324545
6. PL Ho RH Shek KH Chow RS Duan GC Mak EL Lai WC Yam KW Tsang WM Lai 2005 Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002 J Antimicrob Chemother 55 326 332 10.1093/jac/dki010 1:CAS:528:DC%2BD2MXitV2jtL4%3D 15681579 (Pubitemid 40425457)
7. PL Ho AY Ho KH Chow RC Wong RS Duan WL Ho GC Mak KW Tsang WC Yam KY Yuen 2005 Occurrence and molecular analysis of extended-spectrum {beta}-lactamase- producing Proteus mirabilis in Hong Kong, 1999-2002 J Antimicrob Chemother. 55 6 840 845 10.1093/jac/dki135 1:CAS:528:DC%2BD2MXmtVarsrc%3D 15857942 (Pubitemid 40883165)
8. PL Ho WW Poon SL Loke MS Leung KH Chow RC Wong KS Yip EL Lai KW Tsang COMBAT study group 2007 Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women J Antimicrob Chemother 60 140 144 10.1093/jac/dkm144 1:CAS:528:DC%2BD2sXot1ertrs%3D 17496058 (Pubitemid 47073288)
9. TK Ling CM Ying CC Lee ZK Liu 2005 Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong Kong Med Princ Pract 14 338 341 10.1159/000086932 16103700 (Pubitemid 41161009)
10. Y Hirakata J Matsuda Y Miyazaki S Kamihira S Kawakami Y Miyazawa Y Ono N Nakazaki Y Hirata M Inoue JD Turnidge JM Bell RN Jones S Kohno SENTRY Asia-Pacific Participants 2005 Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002) Diagn Microbiol Infect Dis 52 323 329 10.1016/j.diagmicrobio.2005.04.004 16165001 (Pubitemid 41297571)
11. RD Smith J Coast 2002 Antimicrobial resistance: a global response Bull World Health Organ 80 126 133 11953791
12. GS Simonsen JW Tapsall B Allegranzi EA Talbot S Lazzari 2004 The antimicrobial resistance containment and surveillance approach-a public health tool Bull World Health Organ 82 928 934 15654407
13. JJ Marr HL Moffet CM Kunin 1988 Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America J Infect Dis 157 869 876 1:STN:280:DyaL1c7pvFWrsQ%3D%3D 3361154
14. DM Shlaes DN Gerding JF John Jr WA Craig DL Bornstein RA Duncan MR Eckman WE Farrer WH Greene V Lorian S Levy JE McGowan Jr SM Paul J Ruskin FC Tenover C Watanakunakorn 1997 Society for healthcare epidemiology of America and infectious diseases society of america joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals Clin Infect Dis 25 584 599 10.1086/513766 1:STN:280:DyaK2svlvVWitw%3D%3D 9314444 (Pubitemid 127774277)
15. TH Dellit RC Owens JE McGowan Jr DN Gerding RA Weinstein JP Burke WC Huskins DL Paterson NO Fishman CF Carpenter PJ Brennan M Billeter TM Hooton Society for Healthcare Epidemiology of America Infectious Diseases Society of America 2007 Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship Clin Infect Dis 44 159 177 10.1086/510393 17173212 (Pubitemid 46084814)
16. JJ Schentag CH Ballow AL Fritz JA Paladino JD Williams TJ Cumbo RV Ali VA Galletta MB Gutfeld MH Adelman 1993 Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory Diagn Microbiol Infect Dis 16 255 264 10.1016/0732-8893(93)90119-R 1:STN:280:DyaK3s3jvVCkuw%3D%3D 8477582 (Pubitemid 23107311)
17. GL Fraser P Stogsdill JD Dickens Jr DE Wennberg RP Smith Jr BS Prato 1997 Antibiotic optimization. An evaluation of patient safety and economic outcomes Arch Intern Med 157 1689 1694 10.1001/archinte.157.15.1689 1:STN:280: DyaK2szptlOqtw%3D%3D 9250230
18. JG Gums RW Yancey Jr CA Hamilton PS Kubilis 1999 A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team Pharmacotherapy 19 1369 1377 10.1592/phco.19.18. 1369.30898 1:STN:280:DC%2BD3c%2FmslSlug%3D%3D 10600085
19. CD Hamilton R Drew SW Janning JK Latour S Hayward 2000 Excessive use of vancomycin: a successful intervention strategy at an academic medical center Infect Control Hosp Epidemiol 21 42 45 10.1086/501703 1:STN:280: DC%2BD3c7itVWnug%3D%3D 10656355
20. DH Solomon L Van Houten RJ Glynn L Baden K Curtis H Schrager J Avorn 2001 Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center Arch Intern Med 161 1897 1902 10.1001/archinte.161.15.1897 1:STN:280:DC%2BD3MvotFKiug%3D%3D 11493132 (Pubitemid 32762737)
21. CR Kumana TY Ching Y Kong EC Ma M Kou RA Lee VC Cheng SS Chiu WH Seto 2001 Curtailing unnecessary vancomycin usage in a hospital with high rates of methicillin resistant Staphylococcus aureus infections Br J Clin Pharmacol 52 427 432 10.1046/j.0306-5251.2001.01455.x 1:CAS:528:DC%2BD3MXnvVansLs%3D 11678786 (Pubitemid 32939445)
22. P Carling T Fung A Killion N Terrin M Barza 2003 Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years Infect Control Hosp Epidemiol 24 699 706 10.1086/502278 14510254 (Pubitemid 37221343)
23. WH Seto TY Ching M Kou SC Chiang IJ Lauder CR Kumana 1996 Hospital antibiotic prescribing successfully modified by 'immediate concurrent feedback' Br J Clin Pharmacol 41 229 234 10.1111/j.1365-2125.1996.tb00187.x 1:STN:280:DyaK2s%2FitVGntw%3D%3D 8866923
24. PL Ho JC Cheng PT Ching JK Kwan WW Lim WC Tong TC Wu CW Tse R Lam R Yung WH Seto Consensus Meeting Group on Antimicrobial Stewardship Programme 2006 Optimising antimicrobial prescription in hospitals by introducing an antimicrobial stewardship programme in Hong Kong: consensus statement Hong Kong Med J 12 141 148 1:STN:280:DC%2BD287pslChug%3D%3D 16603782
25. M Tumbarello M Sanguinetti E Montuori EM Trecarichi B Posteraro B Fiori R Citton T D'Inzeo G Fadda R Cauda T Spanu 2007 Antimicrob Agents Chemother. 51 1987 1994 10.1128/AAC.01509-06 1:CAS:528:DC%2BD2sXmtlKrsrY%3D 17387156 (Pubitemid 46903084)
26. JP Bru M Michallet C Legrand P Swierz JP Stahl JB Leautet JJ Sotto D Hollard M Micoud 1986 A prospective randomized study comparing the efficacy of Timentin alone or in combination with amikacin in the treatment of febrile neutropenic patients J Antimicrob Chemother 17 Suppl C 203 209 3636335
27. JP Burke 1998 Antibiotic resistance-squeezing the balloon? JAMA 1998 280 1270 1271 10.1001/jama.280.14.1270 (Pubitemid 28469235)
28. L Piroth H Aubé JM Doise M Vincent-Martin 1998 Spread of extended-spectrum beta-lactamase-producingKlebsiella pneumoniae: are beta-lactamase inhibitors of therapeutic value? Clin Infect Dis 27 76 80 10.1086/514643 1:CAS:528:DyaK1cXkvVOktrs%3D 9675456
29. LB Rice V Lakticová MS Helfand R Hutton-Thomas 2004 In vitro antienterococcal activity explains associations between exposures to antimicrobial agents and risk of colonization by multiresistant enterococci J Infect Dis 190 2162 2166 10.1086/425580 1:CAS:528:DC%2BD2MXjslGhtQ%3D%3D 15551215 (Pubitemid 39636364)
30. LB Rice EC Eckstein J DeVente DM Shlaes 1996 Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center Clin Infect Dis 23 118 124 1:STN:280: DyaK28vht1yqtg%3D%3D 8816140
31. CK Lan PR Hsueh WW Wong CP Fung YT Lau JY Yeung GT Young CC Su 2003 Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms J Microbiol Immunol Infect 36 182 186 1:CAS:528:DC%2BD3sXptlWqsrk%3D 14582562
32. PL Ho RC Wong KS Yip SL Loke MS Leung GC Mak FK Chow KW Tsang TL Que COMBAT study group 2007 Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes Diagn Microbiol Infect Dis 59 439 445 10.1016/j.diagmicrobio.2007.06.012 1:CAS:528:DC%2BD2sXhsVWjsLjI 17888610 (Pubitemid 350186333)
33. JJ Rahal C Urban D Horn K Freeman S Segal-Maurer J Maurer N Mariano S Marks JM Burns D Dominick M Lim 1998 Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella JAMA 280 1233 1237 10.1001/jama.280.14.1233 1:CAS:528:DyaK1cXntVejurs%3D 9786372 (Pubitemid 28469228)
34. B Allegranzi R Luzzati A Luzzani F Girardini L Antozzi R Raiteri G Di Perri E Concia 2002 Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections J Hosp Infect 52 136 140 10.1053/jhin.2002.1277 1:STN:280:DC%2BD38njsFeqtg%3D%3D 12392905 (Pubitemid 38001944)
35. KJ Eagye JL Kuti DP Nicolau 2009 Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa Infect Control Hosp Epidemiol 30 746 752 10.1086/603527 19583513
36. ME Falagas P Kopterides 2006 Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature J Hosp Infect 64 7 15 10.1016/j.jhin.2006. 04.015 1:STN:280:DC%2BD28rlvVSiug%3D%3D 16822583 (Pubitemid 44161380)